| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | May 13, 2025 |
| Accession Number: | 0001641172-25-009718 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/5/2023 | $2.00 | Buy | BTIG Research |
4 - Xtant Medical Holdings, Inc. (0001453593) (Issuer)
BTIG Research initiated coverage of Xtant Medical with a rating of Buy and set a new price target of $2.00
3 - Xtant Medical Holdings, Inc. (0001453593) (Issuer)
4 - Xtant Medical Holdings, Inc. (0001453593) (Issuer)
4/A - Xtant Medical Holdings, Inc. (0001453593) (Issuer)
SD - Xtant Medical Holdings, Inc. (0001453593) (Filer)
424B3 - Xtant Medical Holdings, Inc. (0001453593) (Filer)
EFFECT - Xtant Medical Holdings, Inc. (0001453593) (Filer)